Olmesartan Stada (Olmesartan Medoxomil)

Olmesartan medoxil is used to treat high blood pressure by blocking the renin‑angiotensin system.

• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Heart failure: used as part of combination therapy to improve symptoms and outcomes.
• Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes.

• Olmesartan medoxil selectively blocks the binding of angiotensin II to the AT1 receptor on vascular smooth‑muscle cells and adrenal tissue. This inhibition prevents vasoconstriction and aldosterone release, leading to reduced peripheral resistance, lower blood pressure, and decreased sodium and water retention.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dizziness
• Headache
• Fatigue
• Nasal congestion
• Diarrhea
• Back pain

Serious or Rare Side Effects

• Angio‑edema
• Hyperkalemia
• Acute kidney injury
• Severe hypotension
• Liver enzyme elevation
• Bullous skin reactions

When prescribing Olmesartan Stada, clinicians should consider several safety aspects.

• Renal function monitoring: assess baseline creatinine and eGFR before initiation.
• Electrolyte balance: check potassium levels periodically, especially if combined with potassium‑sparing diuretics.
• Pregnancy: contraindicated in the second and third trimesters due to fetal toxicity.
• Concomitant NSAID use: may blunt antihypertensive effect and increase renal risk.
• Elderly patients: start at lower dose and monitor for orthostatic symptoms.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Olmesartan medoxil can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Aliskiren (in diabetic patients): risk of renal dysfunction, hyperkalemia, and hypotension.
• Potassium‑supplement supplements: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely)

• NSAIDs (e.g., ibuprofen): may diminish blood‑pressure‑lowering effect and affect kidney function.
• Diuretics (especially thiazides): can increase risk of electrolyte disturbances.
• Lithium: may raise serum lithium levels, risking toxicity.
• ACE inhibitors or other ARBs: combined use can lead to excessive hypotension and renal impairment.